Glassman Wealth Services Xencor Inc Transaction History

Glassman Wealth Services

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$16.53 - $21.42 $214 - $278	13 New	13 $0
Q2 2022 Aug 04, 2022	BUY	$19.74 - $29.01 $118 - $174	6 New	6 $0
Q1 2022 Apr 14, 2022	SELL	$26.68 - $41.63 $480 - $749	-18 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $606 - $781	18 New	18 $1,000
Q3 2021 Nov 10, 2021	SELL	$30.65 - $35.68 $214 - $249	-7 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$34.33 - $44.68 $240 - $312	7 New	7 $0
Q2 2019 Aug 08, 2019	SELL	$29.6 - $40.93 $621 - $859	-21 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$27.85 - $38.09 $584 - $799	21 New	21 $1,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.